Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose vs Standard-dose Dexamethasone in COVID-19 Pneumonia (PREDEXACOV)
NCT05293210Phase 3Unknown
- Sponsor
- Hospital Universitario Infanta Leonor
- Start
- Feb 2023
- Primary completion
- Nov 2023
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of dexamethasone in COVID-19 pneumonia, sponsored by Hospital Universitario Infanta Leonor. Status: unknown.
02
Drugs
dexamethasone
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT05293210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05293210.